PK and PD of YG1699 in CKD Patients With Diabetes

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

October 30, 2025

Conditions

DiabetesRenal Insufficiency, ChronicHemodialysis

Interventions

DRUG

YG1699

10mg qd for 8 days

DRUG

Placebo

10mg qd for 8 days

Trial Locations (1)

Department of nephrology , Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors

lead

RenJi Hospital

OTHER

NCT06648876 - PK and PD of YG1699 in CKD Patients With Diabetes | Biotech Hunter | Biotech Hunter